Data and Technology

Labcorp Drug Development utilizes unrivaled, proprietary data and technology to improve clinical study outcomes.

Request Demo

Xcellerate® Technology Suite

Xcellerate® is a suite of data and technology enabling solutions designed to increase drug and medical device development efficiency, reduce timelines, improve compliance, and drive commercialization.


"Nobody on the market has this depth of insights related to why patients would/would not join a clinical trial. This [company] is a differentiator and extremely innovative.”

–VP, Top 5 Pharma


Measuring Success of a Quality Risk Management Approach

As regulatory guidance and data collection in clinical trials has evolved, sponsors face pressure to balance quality, productivity and cost for risk management and monitoring. The industry has adopted risk-based quality management (RBQM), yet the methodology is inconsistent. There is no standard way to measure the impact of the different approaches to RBQM on the effectiveness of clinical trial management. Learn more about our approach to establishing and tracking metrics – including those that could apply across the industry – to measure the success of an RBQM approach.

By the Numbers

Site Activation to Last Patient in 4.2 Months Faster vs. The Industry Oncology - Global - Phase I-IV
Recruitment Rate 14% Faster vs. The Industry Oncology - Global - Phase I-IV
Screen Failure 26% Fewer vs. The Industry Oncology - Global - Phase I-IV
Patient Density 63% Better vs. The Industry Cardiology - Global - Phase I-IV


Increase the efficiency and effectiveness of your clinical trials with Xcellerate

Learn More